An observational study in Severe Knee Pain, Severe Knee Disability and Revision Arthroplasty, sponsored by Zimmer, GmbH. Not yet recruiting at 2 sites in 2 countries. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-28.
Sponsored by Zimmer, GmbH · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 268 studies in Pain with a site in Denmark — 36 open to participants now, 42 under way, none of them phase 3. Pain · Denmark.
Among the 268 studies in Pain with a site in Denmark, this one is the 15th largest by planned enrollment of the 53 observational ones that give a count, is one of 12 that started in 2026, is one of 53 observational ones, reaches primary completion later than 39 of the 41 other live ones, and was the 266th registered.
10,076 studies on the registry are indexed under Pain; 1,648 are open to participants now.
Browse Pain studies →36 of the 268 studies in Pain with a site in Denmark are open now. Recruiting first, the newest first:
Danish Headache Center · Sites in Denmark
Ages 18–65
University College Copenhagen · Sites in Denmark
Ages 18–65
Danish Headache Center · Sites in Denmark
Ages 18–65
Aalborg University · Sites in Denmark
Ages 18–80
University of Aarhus · Sites in Denmark
Ages 18+
A study can be open while its sites in Denmark have not opened yet or have stopped. Only those recruiting at a site in Denmark →
Of the 930 Pain studies recruiting now, 384 (41%) set no upper age limit and 434 (47%) stop at 75 or younger; 146 take children under 18; 220 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
268 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 8 · Phase 2 24 · Phase 3 27 · Phase 4 28
First in 2002; this study’s year is marked. 12 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 238 is above the median of 100 across 1,253 observational studies indexed under Pain.
Median enrollment 64 across the 215 interventional studies, 100 across the 53 observational. Of the 198 that completed or were terminated, 17 (9%) have results posted.
This tab as a report to print or save as PDF → With an account.
37 of 268 have an industry lead sponsor. The 10 most frequent:
This study is registered under Zimmer, GmbH, one of the names counted as Zimmer Biomet. Under that name alone:
Zimmer, GmbH is the lead sponsor of 5 studies on the registry; 1 is open to participants now.
Zimmer Biomet has 7 studies filed under Pain — fewer than ten, so there is no comparison to draw.
12 of the studies in Pain with a site in Denmark that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06833749KeyBioscience AGEfficacy and Safety of KBP-336 in Obese Individuals with Osteoarthritis | 2026-11 |
| NCT06678217Copenhagen University Hospital, HvidovreDetection of Electrodermal Activity in Pain 1 | 2026-12-01 |
| NCT06677593Copenhagen University Hospital, HvidovreDetection of Electrodermal Activity in Pain 2 | 2026-12-01 |
| NCT07110324Rigshospitalet, DenmarkCharacteristics of Persistent Pain Composition Following Total Hip or Knee Arthroplasty: a Descriptive Study | 2026-12-01 |
| NCT06257862Aarhus University HospitalTranslation, Cross-cultural Validity and Reliability of a Danish Version of the Anterior Knee Pain Scale | 2026-12-31 |
Add all 12 to your calendar (.ics) → With an account.
Among the 268 studies in Pain with a site in Denmark, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The purpose of this post-market clinical follow-up study is to confirm the long-term safety, performance and clinical benefits of the Persona Revision Knee System Implants and Instrumentation in revision Total Knee Arthroplasty.
Study Design:
This is a multicenter, Prospective, Non-controlled, Non-randomized, Consecutive series of patients, Dual cohort study.
Objectives:
Condition Being Treated/Target population:
The target population for this study consists of patients presenting with a clinically diagnosed necessity for revision total knee arthroplasty with severe knee pain or reduction in functionality resulting in the need for salvage of previously failed surgical attempts, or for a knee in which satisfactory stability in flexion cannot be obtained at the time of surgery
Per indication approved in the European Union and European Economic Area, only revision cases can be included in this study. Full or partial/hybrid revision cases that fall within the revision knee indication are allowed to be included in the study (not first joint replacement).
EC Approval:
The study will require each site to obtain Ethics Committee approval prior to study enrollment. All potential study subjects will be required to participate in the Informed Consent Process.
Length of Study:
12 years including at least 2 years of enrollment and 10 years of follow up.
Subjects must meet all the inclusion criteria and none of the exclusion criteria and receive the study device to participate in this study.
Study subjects will undergo preoperative clinical evaluations prior to their revision knee arthroplasty. The post-operative clinical and radiographic (if standard of care) evaluations will be conducted at 3 months, 1-year, 2-years, 3 -years, 5-years, 7-years and 10-years after implantation.
Data collection will de done in paper and electronic Case Report Forms (CRFs). CRFs will be completed either in-office or hospital at pre-operative, Surgery, Discharge, and the 3 months, 1-year, 2-year, and 5-year intervals. CRFs will be completed either in-office, by phone or by mail at the 3-year, 7-year, and 10-year intervals.
The PMCF is compliant with the following:
Funding: Funding for this clinical study is made available by Zimmer Biomet to support clinical data collection, Ethic Committees review fees and other expenses associated with the conduct and execution of this study protocol
Patients undergoing revision total knee arthroplasty with the Persona Revision Knee System who meet the study eligibility criteria at participating study sites.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
The salvage of previously failed knee surgical attempts or for a knee in which satisfactory stability in flexion cannot be obtained at the time of surgery.
Exclusion Criteria:
Patient has any of the following :
Patient is a member of a vulnerable population group, such as
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Corticosteroids (steroids)
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
From the total sample size (238 cases), 119 cases will be implanted with the Persona Revision Knee and the CCK articular surface.
From the total sample size (238 cases), 119 cases will be implanted with the Persona Revision Knee and CPS or PS articular surface.
Change in Oxford Knee Score (OKS) from Baseline to 2 Years
Average change in Oxford Knee Score (OKS) from baseline to 2 years follow-up. The average change will be evaluated against the Minimal Clinically Important Difference (MCID) of 4.0 points.
Time frame: From baseline (pre-operative assessment) to 2 years after surgery
All-Cause Implant Survival
All-cause survival of the implant system based on removal of any core system component (femoral component, tibial plate, or articular surface) for any reason
Time frame: From surgery up to 10 years post-surgery
Adverse events / Safety
Safety of the Persona Revision Knee System assessed by the frequency and incidence of adverse events, including the relationship of events to the implant, instrumentation, and/or surgical procedure.
Time frame: From surgery up to 10 years of follow-up
Oxford Knee Score - follow-up beyond the primary endpoint
Oxford Knee Score to assess knee pain and functional performance during follow-up. The Oxford Knee Score ranges from 0 to 48, with higher scores indicating better outcomes.
Time frame: Baseline, 3 months, 1 year, 2 years, 3 years (optional), 5 years, 7 years (optional), and 10 years post-surgery
EQ-5D-5L Health Related Quality of Life
EQ-5D-5L to assess subject health-related quality of life during follow-up.Health-related quality of life will be assessed using the EuroQol 5-Dimension 5-Level questionnaire (EQ-5D-5L). The descriptive system includes five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension is rated on a 5-level scale, from level 1 (no problems) to level 5 (extreme problems or inability), with higher levels indicating worse health status. The EQ visual analogue scale (EQ VAS) ranges from 0 to 100, with higher scores indicating better self-rated health.
Time frame: Baseline, 3 months, 1 year, 2 years, 3 years (optional), 5 years, 7 years (optional), and 10 years post-surgery
Patient Satisfaction with the Study Knee and Treatment
Patient Satisfaction Questionnaire to assess patient satisfaction with the study knee and treatment. Patient satisfaction with the study knee and treatment will be assessed using the Patient Satisfaction Questionnaire. The questionnaire includes three questions: usual knee pain during the past 4 weeks, satisfaction with the knee replacement, and willingness to undergo the surgery again. Responses are categorical and will be summarized descriptively; no total questionnaire score will be calculated. Knee pain is rated as None, Very mild, Mild, Moderate, or Severe, with higher severity indicating worse outcome. Satisfaction is rated as Very satisfied, Satisfied, Neutral, Dissatisfied, or Very dissatisfied, with higher satisfaction indicating better outcome. Willingness to undergo surgery again is recorded as Yes or No.
Time frame: 3 months, 1 year, 2 years, 3 years (optional), 5 years, 7 years (optional), and 10 years post-surgery
Percentage (%) of Participants with significant radiographic findings
Presence or absence of significant radiographic findings will be assessed by standard-of-care radiographs. If a significant finding is identified, the type of finding is documented, including osteolysis, radiolucency, radiodensity, bone loss, subsidence, heterotopic ossification, fracture, implant loosening, articular surface wear, patellar dislocation, subluxation, tilt, or other significant findings. The amount of the finding may be recorded in millimeters (mm) or degrees, when applicable.
Time frame: From baseline up to 10 years after surgery
Plan to share: Undecided — A decision regarding the sharing of individual participant data (IPD) has not yet been made and will be determined at a later stage of the study.
No publications or documents are linked to this record.
Start is estimated for Sep 2026; primary completion for Sep 2030, 48 months later.
Of 520 observational studies under Pain, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 41. This study's planned 48 months is above that.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.